Marquette Asset Management’s Pliant Therapeutics PLRX Stock Holding History

Marquette Asset Management’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$199K	Buy	+174,500	New	+$212K	0.03%	103

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Marquette Asset Management's PLRX Position: Q2 2026 in Review

Marquette Asset Management opened a new position in Pliant Therapeutics (PLRX) in Q2 2026: 174,500 shares worth $199K. The stake represents 0.03% of the portfolio and ranks #103 among its holdings.

86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

Marquette Asset Management held 174,500 shares of Pliant Therapeutics worth $199K as of Q2 2026.
Pliant Therapeutics was a new Marquette Asset Management position in Q2 2026.
Pliant Therapeutics made up 0.03% of Marquette Asset Management's portfolio in Q2 2026, its #103 holding.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.